Collectively, our study suggested that SCARA3 is potentially associated with age-related metabolic dysfunction, which provided new insights into the pathogenesis and treatment of obesity as well as other obesity-associated metabolic complications. Here, SCARA3 is linked to obesity due to melanocortin 4 receptor deficiency.